News
Hosted on MSN10d
Inflammatory Markers Linked to Severe Attacks in Moderate AsthmaInflammatory markers boosted asthma attack prediction, potentially allowing intensification of treatment, according to a meta ...
5d
MedPage Today on MSNBest Time of Day for Asthma Inhaler?An afternoon dose also yielded significantly better overnight (10 p.m. to 4 a.m.) suppression in blood eosinophil counts as a ...
Water Intoxication: A 72-year-old Chinese man was hospitalised after drinking excess water, triggering the worst asthma ...
Blue Cross Blue Shield mandates severe asthma patients self-administer drugs at home, unless their provider gets prior approval from the company.
Drilling down into subgroups of patients, Sanofi also claimed that amlitelimab demonstrated “compelling efficacy” in patients ...
For millions of people around the world, asthma is more than just a breathing problem—it is a chronic and often debilitating ...
Rümeysa Öztürk said she has experienced several asthma attacks while in custody at a Louisiana facility, and had her hijab ...
3don MSN
Crooks advises that asthma, which is one of the most common health conditions, can develop over the course of someone's life, ...
Routine Asthma Test More Reliable in the Morning and Has Seasonal Effects, Say Doctors Mar. 12, 2025 — A lung function test used to help diagnose asthma works better in the morning, becoming ...
4d
News Medical on MSNSingle mid-afternoon preventer inhaler dose may be best timing for asthma controlA single daily preventer dose of inhaled corticosteroid (beclomethasone), taken at mid-afternoon, may be the best timing for ...
Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate-to-severe asthma. Amlitelimab ...
Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results